Satwant K. Narula

Biography

Satwant’s major research focus has always been on New Drug Discovery and Development. Expertise base comprises a successful track record in progressing Biological drugs and small molecule therapeutics into the Clinic with a strong focus on personalized health care/biomarker approach to drug development. She led over 20 molecules into clinical development. Disease areas of focus have included autoimmune diseases, Respiratory diseases, fibrosis, infectious diseases, immune tolerance and cancer immunotherapy. Satwant was Vice President at Bristol-Myers Squibb, Roche Pharmaceuticals, and Schering-Plough. Over the course of her career in Schering-Plough, she was involved in programs that resulted in marketed drugs such as IntronA, Remicade and Posaconazole.

Research Interest

immunotherapy